MRI Interventions, a commercial stage medical technology company, is focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures. The company s FDA cleared and CE marked ClearPoint system utilizes a hospital s existing diagnostic or intraoperative MRI scanner to enable a range of minimally invasive procedures in the brain. Building on the imaging power of MRI, the company s interventional platforms strive to improve patient care while reducing procedure costs and times. For more information, please visit www.MRIInterventions.com.
Quote | MRI Interventions (OTCMKTS:MRIC)
Last: | $ |
---|---|
Change Percent: | -0.48% |
Open: | $5.04 |
Close: | $5.135 |
High: | $5.36 |
Low: | $5.03 |
Volume: | 51,602 |
Last Trade Date Time: | 02/11/2020 04:55:22 pm |
News | MRI Interventions (OTCMKTS:MRIC)
IRVINE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the market close. The Company wi...
IRVINE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the market close. Investors a...
Message Board Posts | MRI Interventions (OTCMKTS:MRIC)
Subject | By | Source | When |
---|---|---|---|
SP Looks like a good place to bounce | The oNiOnHEAd | investorshub | 11/18/2021 7:14:52 AM |
$MRIC now trading as CLPT Clearpoint Neuro Inc. | nsomniyak | investorshub | 02/12/2020 9:12:03 PM |
Things are looking up despite the weakness of | Kaptain | investorshub | 01/21/2020 9:18:05 PM |
Any body home? Liked Q4 and infusion of | boatguycharles | investorshub | 01/20/2020 8:47:48 PM |
It seems that it will not be available | Kaptain | investorshub | 12/20/2019 8:38:43 PM |
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the market close. The Company wi...
IRVINE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the market close. Investors a...
IRVINE, Calif., April 17, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) is pleased to announce that Matthew B. Klein, MD, MS, FACS, has been appointed to ClearPoint Neuro’s Board of Directors effective immediately. Dr. Klein, Chief Development Officer of PTC Therapeu...